当前位置: X-MOL 学术Lancet › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Targeted radiotherapy for early breast cancer
The Lancet ( IF 98.4 ) Pub Date : 2018-01-06 , DOI: 10.1016/s0140-6736(17)33316-0
Jayant S Vaidya , Max Bulsara , Frederik Wenz , Jeffrey S Tobias , David Joseph , Michael Baum

We congratulate Charlotte E Coles and colleagues (Sept 9, 2017, p 1048)1 on their randomised trial (IMPORT LOW) ratifying partial-breast irradiation and confirming the original hypothesis2 proposed in The Lancet 20 years ago.3 In 2010, the independent commentary accompanying the first results of the TARGIT-A trial4 of single-dose targeted intraoperative radiotherapy (TARGIT-IORT), published in The Lancet by the authors of this letter, presented partial-breast irradiation as the new standard for suitable patients.

中文翻译:

早期乳腺癌的靶向放疗

我们祝贺Charlotte E Coles及其同事(2017年9月9日,第1048页)1批准了部分乳房照射并确认20年前《柳叶刀》提出的原始假设2的随机试验(IMPORT LOW)。3 2010年,本信作者发表在《柳叶刀》杂志上的TARGIT-A单剂量靶向术中放疗试验4(TARGIT-IORT)的第一批结果随附的独立评论提出了新的部分乳房放疗适合患者的标准。
更新日期:2018-01-05
down
wechat
bug